Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies DOI Open Access
Sravani Ramisetty,

Ayalur Raghu Subbalakshmi,

Siddhika Pareek

и другие.

Journal of Clinical Medicine, Год журнала: 2024, Номер 13(11), С. 3337 - 3337

Опубликована: Июнь 5, 2024

Cancer cells, like all other organisms, are adept at switching their phenotype to adjust the changes in environment. Thus, phenotypic plasticity is a quantitative trait that confers fitness advantage cancer cell by altering its suit environmental circumstances. Until recently, new traits, especially cancer, were thought arise due genetic factors; however, it now amply evident such traits could also emerge non-genetically plasticity. Furthermore, of cells contributes heterogeneity population, which major impediment treating disease. Finally, impacts group behavior since competition and cooperation among multiple clonal groups within population interactions they have with tumor microenvironment contribute evolution drug resistance. understanding mechanisms exploit tailor phenotypes systems level can aid development novel therapeutics treatment strategies. Here, we present our perspective on team medicine-based approach gain deeper phenomenon develop therapeutic

Язык: Английский

Estimating treatment sensitivity in synthetic and in vitro tumors using a random differential equation model DOI Creative Commons

Natalie Meacham,

Erica M. Rutter

npj Systems Biology and Applications, Год журнала: 2025, Номер 11(1)

Опубликована: Май 23, 2025

Abstract Resistance to treatment, which comes from the heterogeneity of cell types within tumors, is a leading cause poor treatment outcomes in cancer patients. Previous mathematical work modeling over time has neither emphasized relationship between and resistance nor depicted with sufficient nuance. To respond need depict wide range levels, we develop random differential equation model tumor growth. Random equations are parameters variables. In inverse problem, aim recover sensitivity as probability mass function. This allows us observe what proportions cells exist at different levels. After validating method synthetic data, apply it monoclonal mixture population data isogenic Ba/F3 murine lines uncover each tumor’s levels

Язык: Английский

Процитировано

0

Bringing evolutionary cancer therapy to the clinic: a systems approach DOI Creative Commons
Arina Soboleva, I Grossmann, Anne‐Marie C. Dingemans

и другие.

npj Systems Biology and Applications, Год журнала: 2025, Номер 11(1)

Опубликована: Май 27, 2025

Язык: Английский

Процитировано

0

Overcoming chemotherapy resistance in low-grade gliomas: A computational approach DOI Creative Commons
Thibault Delobel, Luis E. Ayala-Hernández, Jesús J. Bosque

и другие.

PLoS Computational Biology, Год журнала: 2023, Номер 19(11), С. e1011208 - e1011208

Опубликована: Ноя. 20, 2023

Low-grade gliomas are primary brain tumors that arise from glial cells and usually treated with temozolomide (TMZ) as a chemotherapeutic option. They often incurable, but patients have prolonged survival. One of the shortcomings treatment is eventually develop drug resistance. Recent findings show persisters, enter dormancy state to resist treatment, play an important role in development resistance TMZ. In this study we constructed mathematical model low-grade glioma response TMZ incorporating persister population. The was able describe volumetric longitudinal dynamics, observed routine FLAIR 3D sequences, acquiring We used explore different administration protocols, first on virtual clones real afterwards preserving relationships between parameters patients. silico clinical trials showed deferred by protocols which individual doses administered after rest periods, rather than 28-days cycle standard protocol. This led median survival gains more 15 months when using resting periods two three weeks agreed recent experimental observations animal models. Additionally, tested adaptive variations these new what potential reduction toxicity, no gain. Our computational results highlight need further could obtain better low grade gliomas.

Язык: Английский

Процитировано

8

Coexistence of Competing Microbial Strains under Twofold Environmental Variability and Demographic Fluctuations DOI Creative Commons
Matthew Asker, Lluís Hernández-Navarro, A. M. Rucklidge

и другие.

New Journal of Physics, Год журнала: 2023, Номер 25(12), С. 123010 - 123010

Опубликована: Ноя. 16, 2023

Abstract Microbial populations generally evolve in volatile environments, under conditions fluctuating between harsh and mild, e.g. as the result of sudden changes toxin concentration or nutrient abundance. Environmental variability (EV) thus shapes long-time population dynamics, notably by influencing ability different strains microorganisms to coexist. Inspired evolution antimicrobial resistance, we study dynamics a community consisting two competing subject twofold EV. The level varies time, favouring growth one strain low drug other when is high. We also model time-changing resource abundance randomly switching carrying capacity that drives size community. While dominates static environment, show species coexistence possible presence By computational analytical means, determine environmental which long-lived it almost certain. Notably, circumstances demographic fluctuations promote, hinder, coexistence. how make-up phase average each depend on

Язык: Английский

Процитировано

6

Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies DOI Open Access
Sravani Ramisetty,

Ayalur Raghu Subbalakshmi,

Siddhika Pareek

и другие.

Journal of Clinical Medicine, Год журнала: 2024, Номер 13(11), С. 3337 - 3337

Опубликована: Июнь 5, 2024

Cancer cells, like all other organisms, are adept at switching their phenotype to adjust the changes in environment. Thus, phenotypic plasticity is a quantitative trait that confers fitness advantage cancer cell by altering its suit environmental circumstances. Until recently, new traits, especially cancer, were thought arise due genetic factors; however, it now amply evident such traits could also emerge non-genetically plasticity. Furthermore, of cells contributes heterogeneity population, which major impediment treating disease. Finally, impacts group behavior since competition and cooperation among multiple clonal groups within population interactions they have with tumor microenvironment contribute evolution drug resistance. understanding mechanisms exploit tailor phenotypes systems level can aid development novel therapeutics treatment strategies. Here, we present our perspective on team medicine-based approach gain deeper phenomenon develop therapeutic

Язык: Английский

Процитировано

2